Colgate-Palmolive (NYSE:CL) Shares Acquired by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. raised its position in Colgate-Palmolive (NYSE:CL - Free Report) by 166.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 67,200 shares of the company's stock after acquiring an additional 42,000 shares during the period. Colgate-Palmolive makes up approximately 1.8% of Hussman Strategic Advisors Inc.'s holdings, making the stock its 2nd biggest holding. Hussman Strategic Advisors Inc.'s holdings in Colgate-Palmolive were worth $6,109,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp increased its holdings in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after acquiring an additional 1,784,411 shares in the last quarter. Geode Capital Management LLC boosted its stake in Colgate-Palmolive by 2.8% in the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock worth $2,095,325,000 after purchasing an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in Colgate-Palmolive by 6.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock worth $988,997,000 after purchasing an additional 557,492 shares during the last quarter. Barclays PLC increased its stake in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. Finally, FMR LLC raised its holdings in shares of Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company's stock worth $700,642,000 after buying an additional 2,674,807 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

CL stock traded up $1.69 during mid-day trading on Friday, reaching $89.56. 4,747,229 shares of the company's stock were exchanged, compared to its average volume of 4,884,892. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a 12-month low of $84.45 and a 12-month high of $109.30. The stock's 50 day moving average is $89.02 and its 200 day moving average is $95.99. The company has a market cap of $72.68 billion, a price-to-earnings ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the business posted $0.87 EPS. On average, research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were given a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.23%. Colgate-Palmolive's dividend payout ratio (DPR) is 56.82%.

Analyst Upgrades and Downgrades

CL has been the topic of a number of research analyst reports. Stifel Nicolaus dropped their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a report on Monday, February 3rd. Barclays lowered their price target on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research report on Friday, January 17th. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. Finally, Morgan Stanley cut their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.